Obesity Clinical Trial
— FISK2Official title:
Fiskespisestudiene 2011-2014. Spiseforsøk Med Fisk. Delstudie 2: Studie av Mulige Effekter av Fet og Mager Fisk på Glukosemetabolismen og inflammasjonsmarkører i Overvektige Voksne.
| NCT number | NCT02350595 |
| Other study ID # | FISK2 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | August 2011 |
| Est. completion date | December 2012 |
| Verified date | December 2021 |
| Source | University of Bergen |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The potential health effects of high intake of lean or fatty fish will be investigated in overweight or obese adults. Participants consume 750g/week of fillets of fish for 8 weeks. Hypothesis: High intake of fatty or lean fish will beneficially affect glucose regulation and the immune system.
| Status | Completed |
| Enrollment | 76 |
| Est. completion date | December 2012 |
| Est. primary completion date | December 2012 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 69 Years |
| Eligibility | Inclusion Criteria: - BMI =27 kg/m2 - fasting blood glucose =7.0 mmol/L Exclusion Criteria: - pregnancy - incompatibility with fish consumption (allergies, intolerance and/or dislike) - diagnosed diabetes mellitus, heart disease or gastrointestinal diseases - use of medications affecting lipid metabolism or glucose homeostasis - use of anti-inflammatory medications - use of supplements containing long chain n-3 fatty acids - intentional weight loss - and large fluctuation in body weight (>3 kg) over the previous two months |
| Country | Name | City | State |
|---|---|---|---|
| Norway | Haukeland University Hospital | Bergen |
| Lead Sponsor | Collaborator |
|---|---|
| University of Bergen | Bergen Medical Research Foundation, Leroy Seafood Group ASA, Skretting ASA |
Norway,
Bratlie M, Hagen IV, Helland A, Erchinger F, Midttun Ø, Ueland PM, Rosenlund G, Sveier H, Mellgren G, Hausken T, Gudbrandsen OA. Effects of high intake of cod or salmon on gut microbiota profile, faecal output and serum concentrations of lipids and bile a — View Citation
Bratlie M, Hagen IV, Helland A, Midttun Ø, Ulvik A, Rosenlund G, Sveier H, Mellgren G, Ueland PM, Gudbrandsen OA. Five salmon dinners per week were not sufficient to prevent the reduction in serum vitamin D in autumn at 60° north latitude: a randomised tr — View Citation
Hagen IV, Helland A, Bratlie M, Midttun Ø, McCann A, Sveier H, Rosenlund G, Mellgren G, Ueland PM, Gudbrandsen OA. TMAO, creatine and 1-methylhistidine in serum and urine are potential biomarkers of cod and salmon intake: a randomised clinical trial in ad — View Citation
Helland A, Bratlie M, Hagen IV, Midttun Ø, Sveier H, Mellgren G, Ueland PM, Gudbrandsen OA. Effect of high intake of cod or salmon on serum total neopterin concentration: a randomised clinical trial. Eur J Nutr. 2021 Sep;60(6):3237-3248. doi: 10.1007/s003 — View Citation
Helland A, Bratlie M, Hagen IV, Mjøs SA, Sørnes S, Ingvar Halstensen A, Brokstad KA, Sveier H, Rosenlund G, Mellgren G, Gudbrandsen OA. High intake of fatty fish, but not of lean fish, improved postprandial glucose regulation and increased the n-3 PUFA co — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Changes in serum concentrations of glucose | baseline and 8 weeks | ||
| Secondary | Changes in insulin, insulin C-peptide, leukocyte fatty acids, leukocyte function, body weight and composition, and intake of energy and macronutrients within the groups over time. | baseline and 8 weeks | ||
| Secondary | Changes in serum vitamin concentrations after fish intake. | Serum concentrations of fat-soluble and water-soluble vitamins were measured, and dietary intakes of vitamins were estimated based on reported food intake from 5-day food diaries. | baseline and 8 weeks | |
| Secondary | Changes in serum and urine concentrations of amino acids and metabolites of amino acids after fish intake. | Concentrations of amino acids and amino acid metabolites were measured in fasting serum and morning urine | baseline and 8 weeks | |
| Secondary | Changes in fecal microbiota profile after fish intake. | 54 DNA bacterial markers targeting more than 300 bacteria based on their 16S rRNA sequence in seven variable regions were analysed in feces (72h collection) | baseline and 8 weeks | |
| Secondary | Changes in fecal and serum concentrations of lipids and bile acids after fish intake. | Fat, cholesterol and total bile acids were quantified in feces (72h collection) and fasting serum. | baseline and 8 weeks | |
| Secondary | Changes in markers of oxidative stress after fish intake. | Antioxidant enzymes, antioxidant enzyme cofactors and biomarkers of oxidative stress were quantified in serum | baseline and 8 weeks | |
| Secondary | Changes in total neopterin after fish intake | Total neopterin was measured in serum. | baseline and 8 weeks | |
| Secondary | Quantification of markers of kidney dysfunction | Urine concentrations of cystatin C and T-cell immunoglobulin mucin-1 (relative to creatinine) were measured as markers of kidney function | baseline and 8 weeks | |
| Secondary | Changes in amino acids and metabolites of amino acids after a standardized meal. | Concentrations of amino acids and amino acid metabolites were measured in fasting and postprandial serum | baseline | |
| Secondary | Changes in metabolites and co-factors involved in one-carbon metabolism after a standardized meal | Concentrations of relevant metabolites and co-factors were measured in fasting and postprandial serum | baseline | |
| Secondary | Comparisons of amino acid concentrations in serum and urine between men and women | Concentrations of amino acids and amino acid metabolites were measured in serum and urine | baseline | |
| Secondary | Comparisons of metabolites and co-factors involved in one-carbon metabolism in serum and urine between men and women | Concentrations of relevant metabolites and co-factors were measured in serum and urine | baseline |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |